Fresenius Medical Care Deutschland GmbH, Bad Homburg, Hessen, Germany.
Renal Research Institute, New York, New York, USA.
Hemodial Int. 2022 Apr;26(2):264-273. doi: 10.1111/hdi.12986. Epub 2021 Dec 12.
Inadequate fluid status remains a key driver of cardiovascular morbidity and mortality in chronic hemodialysis (HD) patients. Quantification of fluid overload (FO) using bioimpedance spectroscopy (BIS) has become standard in many countries. To date, no BIS device has been approved in the United States for fluid status assessment in kidney patients. Therefore, no previous quantification of fluid status in US kidney patients using BIS has been reported. Our aim was to conduct a cross-sectional BIS-based assessment of fluid status in an urban US HD population.
We determined fluid status in chronic HD patients using whole body BIS (Body Composition Monitor, BCM). The BCM reports FO in liters; negative FO denotes fluid depletion. Measurements were performed before dialysis. Post-HD FO was estimated by subtracting the intradialytic weight loss from the pre-HD FO.
We studied 170 urban HD patients (age 61 ± 14 years, 60% male). Pre- and post-HD FO (mean ± SD), were 2.2 ± 2.4 and -0.2 ± 2.7 L, respectively. Pre-HD, 43% of patients were fluid overloaded, 53% normally hydrated, and 4% fluid depleted. Post-HD, 12% were fluid overloaded, 55% normohydrated and 32% fluid depleted. Only 48% of fluid overloaded patients were hypertensive, while 38% were normotensive and 14% hypotensive. Fluid status did not differ significantly between African Americans (N = 90) and Caucasians (N = 61).
While about half of the patients had normal fluid status pre-HD, a considerable proportion of patients was either fluid overloaded or depleted, indicating the need for tools to objectively quantify fluid status.
在慢性血液透析(HD)患者中,液体状态不足仍然是心血管发病率和死亡率的关键驱动因素。使用生物阻抗谱(BIS)量化液体超负荷(FO)已在许多国家成为标准。迄今为止,还没有任何 BIS 设备获得美国批准用于评估肾病患者的液体状态。因此,以前没有报告过使用 BIS 在美国肾病患者中评估液体状态的情况。我们的目的是使用基于 BIS 的横断面研究来评估美国城市 HD 人群的液体状态。
我们使用全身 BIS(身体成分监测仪,BCM)来确定慢性 HD 患者的液体状态。BCM 以升报告 FO;负 FO 表示液体耗竭。测量是在透析前进行的。透析后 FO 通过从透析前 FO 中减去透析期间的体重减轻量来估计。
我们研究了 170 名城市 HD 患者(年龄 61±14 岁,60%为男性)。透析前和透析后 FO(平均值±标准差)分别为 2.2±2.4 和-0.2±2.7 L。透析前,43%的患者存在液体超负荷,53%的患者处于正常水化状态,4%的患者存在液体耗竭。透析后,12%的患者存在液体超负荷,55%的患者处于正常水化状态,32%的患者存在液体耗竭。只有 48%的液体超负荷患者患有高血压,而 38%的患者血压正常,14%的患者血压偏低。非洲裔美国人(N=90)和白种人(N=61)之间的液体状态没有显著差异。
虽然约有一半的患者在透析前液体状态正常,但相当一部分患者存在液体超负荷或耗竭,这表明需要使用工具来客观地量化液体状态。